Glycogen Storage Disease Type Ib: The First Case in Taiwan
Glycogen storage disease (GSD) type Ib is caused by the deficiency of glucose-6-phosphate translocase activity. The elder brother of the proband died at age 20 months, and GSD Ia, a disease caused by the deficiency of glucose-6-phosphatase, was the diagnosis. The proband developed hypoglycemia short...
Main Authors: | Hui-Ju Hsiao, Hsiu-Hao Chang, Wuh-Liang Hwu, Ching-Wan Lam, Ni-Chung Lee, Yin-Hsiu Chien |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2009-06-01
|
Series: | Pediatrics and Neonatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1875957209600486 |
Similar Items
-
Protective effects of Ziziphus Jujube on clinical and paraclinical findings of glycogen storage disease Ib, a case report and literature review
by: shahsanam Geibi, et al.
Published: (2017-11-01) -
Patient‐reported outcomes on empagliflozin treatment in glycogen storage disease type Ib: An international questionnaire study
by: Sarah C. Grünert, et al.
Published: (2023-05-01) -
Two successful pregnancies and first use of empagliflozin during pregnancy in glycogen storage disease type Ib
by: Sarah Catharina Grünert, et al.
Published: (2022-07-01) -
Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib
by: Sarah C. Grünert, et al.
Published: (2020-08-01) -
Finding balance between mature and immature neutrophils: The effects of empagliflozin in GSD‐Ib
by: Fabiola Guerra, et al.
Published: (2023-05-01)